SEC FILINGS


Form DEF 14A
ACADIA PHARMACEUTICALS INC filed this Form DEF 14A on 04/30/2019
Document Outline
Entire Document (1381.1 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - SCHEDULE 14A INFORMATION
Page 2 - ACADIA PHARMACEUTICALS INC.
Page 3 - ACADIA PHARMACEUTICALS INC.
Page 4 - What am I voting on?
Page 5 - We provide on-line proxy voting to allow you to vote your shares online, with procedures designed to
Page 6 - When are stockholder proposals due for next year s annual meeting?
Page 7 - How many votes are needed to approve each proposal?
Page 8 - How can I find out the results of the voting at the annual meeting?
Page 9 - PROPOSAL 1
Page 10 - Nominees for Election for a Three-year Term Expiring at the 2022 Annual Meeting
Page 11 - Directors Continuing in Office Until the 2020 Annual Meeting
Page 12 - N/A
Page 13 - INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
Page 14 - Meetings of the Board of Directors
Page 15 - Report of the Audit Committee of the Board of Directors
Page 16 - N/A
Page 17 - N/A
Page 18 - Nominating and Corporate Governance Committee
Page 19 - Stockholder Communications With the Board of Directors
Page 20 - PROPOSAL 2
Page 21 - The Size of Our Share Reserve Increase Request Is Reasonable
Page 22 - Burn Rate
Page 23 - General 2010 Plan Information
Page 24 - THE BOARD OF DIRECTORS RECOMMENDS
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - Interest of Certain Persons in the Amended 2010 Plan
Page 33 - Equity Compensation Plan Information
Page 34 - PROPOSAL 3
Page 35 - General Amended Purchase Plan Information
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - U.S. Federal Income Tax Information
Page 40 - PROPOSAL 4
Page 41 - PROPOSAL 5
Page 42 - THE BOARD OF DIRECTORS RECOMMENDS
Page 43 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 44 - N/A
Page 45 - EXECUTIVE COMPENSATION
Page 46 - Pay for Performance in 2018
Page 47 - Say-on-Pay and Stockholder Engagement
Page 48 - Positive Pay Practices
Page 49 - Alder BioPharma
Page 50 - Corcept Therapeutics
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - Compensation Risk Assessment
Page 56 - Compensation Committee Report
Page 57 - Summary Compensation Table
Page 58 - N/A
Page 59 - Grants of Plan-Based Awards
Page 60 - N/A
Page 61 - Outstanding Equity Awards at Fiscal Year-End
Page 62 - Option Exercises and Stock Vested
Page 63 - N/A
Page 64 - N/A
Page 65 - CEO Pay Ratio Disclosure
Page 66 - N/A
Page 67 - N/A
Page 68 - TRANSACTIONS WITH RELATED PERSONS
Page 69 - Director Independence
Page 70 - HOUSEHOLDING OF PROXY MATERIALS
Page 71 - OTHER MATTERS
Page 72 - Appendix A
Page 73 - N/A
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - N/A
Page 78 - N/A
Page 79 - N/A
Page 80 - N/A
Page 81 - N/A
Page 82 - N/A
Page 83 - N/A
Page 84 - N/A
Page 85 - N/A
Page 86 - N/A
Page 87 - N/A
Page 88 - N/A
Page 89 - N/A
Page 90 - N/A
Page 91 - N/A
Page 92 - Appendix B
Page 93 - N/A
Page 94 - N/A
Page 95 - N/A
Page 96 - N/A
Page 97 - N/A
Page 98 - N/A
Page 99 - USE OF PROCEEDS
Page 100 - N/A
Page 101 - N/A
Page 102 - N/A